Skip to main navigation Skip to search Skip to main content

Development of 5-fluorouracil derivatives as anticancer agents

  • Xiaoyan Pan
  • , Chen Wang
  • , Fang Wang
  • , Pengfei Li
  • , Zhigang Hu
  • , Yuanyuan Shan
  • , Jie Zhang
  • Xi'an Jiaotong University

Research output: Contribution to journal › Review article › peer-review

63 Scopus citations

Abstract

5-Fluorouracil (5-FU) is one of the most potent antimetabolites which have been widely used in the treatment of advancedsolid tumors. As an anticancer agent, because of its low efficacy and high toxicity, numerous modifications of 5-FU structure have beenperformed. A great number of novel 5-FU derivatives have been developed with highly efficient and much less toxic. In this paper, therecent development of novel 5-FU derivatives as potent antitumor agents is reviewed and discussed.

Original languageEnglish
Pages (from-to)4538-4556
Number of pages19
JournalCurrent Medicinal Chemistry
Volume18
Issue number29
DOIs
StatePublished - Oct 2011

Keywords

  • 5-Fluorouracil (5-FU)
  • Anticancer
  • Antimetabolite
  • Thymidylate synthase
  • Toxicity

Fingerprint

Dive into the research topics of 'Development of 5-fluorouracil derivatives as anticancer agents'. Together they form a unique fingerprint.

Cite this